IBDEI1GT ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23699,1,3,0)
 ;;=3^Diffuse Cystic Mastopathy,Right Breast
 ;;^UTILITY(U,$J,358.3,23699,1,4,0)
 ;;=4^N60.11
 ;;^UTILITY(U,$J,358.3,23699,2)
 ;;=^5015773
 ;;^UTILITY(U,$J,358.3,23700,0)
 ;;=N60.12^^82^1032^58
 ;;^UTILITY(U,$J,358.3,23700,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23700,1,3,0)
 ;;=3^Diffuse Cystic Mastopathy,Left Breast
 ;;^UTILITY(U,$J,358.3,23700,1,4,0)
 ;;=4^N60.12
 ;;^UTILITY(U,$J,358.3,23700,2)
 ;;=^5015774
 ;;^UTILITY(U,$J,358.3,23701,0)
 ;;=N73.9^^82^1032^78
 ;;^UTILITY(U,$J,358.3,23701,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23701,1,3,0)
 ;;=3^Female Pelvic Inflamm Dis,Unspec
 ;;^UTILITY(U,$J,358.3,23701,1,4,0)
 ;;=4^N73.9
 ;;^UTILITY(U,$J,358.3,23701,2)
 ;;=^5015820
 ;;^UTILITY(U,$J,358.3,23702,0)
 ;;=N72.^^82^1032^86
 ;;^UTILITY(U,$J,358.3,23702,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23702,1,3,0)
 ;;=3^Inflammatory Disease of Cervix Uteri
 ;;^UTILITY(U,$J,358.3,23702,1,4,0)
 ;;=4^N72.
 ;;^UTILITY(U,$J,358.3,23702,2)
 ;;=^5015812
 ;;^UTILITY(U,$J,358.3,23703,0)
 ;;=N76.0^^82^1032^133
 ;;^UTILITY(U,$J,358.3,23703,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23703,1,3,0)
 ;;=3^Vaginitis,Acute
 ;;^UTILITY(U,$J,358.3,23703,1,4,0)
 ;;=4^N76.0
 ;;^UTILITY(U,$J,358.3,23703,2)
 ;;=^5015826
 ;;^UTILITY(U,$J,358.3,23704,0)
 ;;=N76.1^^82^1032^135
 ;;^UTILITY(U,$J,358.3,23704,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23704,1,3,0)
 ;;=3^Vaginitis,Subacute & Chronic
 ;;^UTILITY(U,$J,358.3,23704,1,4,0)
 ;;=4^N76.1
 ;;^UTILITY(U,$J,358.3,23704,2)
 ;;=^5015827
 ;;^UTILITY(U,$J,358.3,23705,0)
 ;;=N81.3^^82^1032^128
 ;;^UTILITY(U,$J,358.3,23705,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23705,1,3,0)
 ;;=3^Uterovaginal Prolapse,Complete
 ;;^UTILITY(U,$J,358.3,23705,1,4,0)
 ;;=4^N81.3
 ;;^UTILITY(U,$J,358.3,23705,2)
 ;;=^5015840
 ;;^UTILITY(U,$J,358.3,23706,0)
 ;;=N81.2^^82^1032^129
 ;;^UTILITY(U,$J,358.3,23706,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23706,1,3,0)
 ;;=3^Uterovaginal Prolapse,Incomplete
 ;;^UTILITY(U,$J,358.3,23706,1,4,0)
 ;;=4^N81.2
 ;;^UTILITY(U,$J,358.3,23706,2)
 ;;=^5015839
 ;;^UTILITY(U,$J,358.3,23707,0)
 ;;=N81.4^^82^1032^130
 ;;^UTILITY(U,$J,358.3,23707,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23707,1,3,0)
 ;;=3^Uterovaginal Prolapse,Unspec
 ;;^UTILITY(U,$J,358.3,23707,1,4,0)
 ;;=4^N81.4
 ;;^UTILITY(U,$J,358.3,23707,2)
 ;;=^5015841
 ;;^UTILITY(U,$J,358.3,23708,0)
 ;;=N87.9^^82^1032^67
 ;;^UTILITY(U,$J,358.3,23708,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23708,1,3,0)
 ;;=3^Dysplasia of Cervix Uteri,Unspec
 ;;^UTILITY(U,$J,358.3,23708,1,4,0)
 ;;=4^N87.9
 ;;^UTILITY(U,$J,358.3,23708,2)
 ;;=^5015877
 ;;^UTILITY(U,$J,358.3,23709,0)
 ;;=N87.0^^82^1032^45
 ;;^UTILITY(U,$J,358.3,23709,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23709,1,3,0)
 ;;=3^Cervical Dysplasia,Mild
 ;;^UTILITY(U,$J,358.3,23709,1,4,0)
 ;;=4^N87.0
 ;;^UTILITY(U,$J,358.3,23709,2)
 ;;=^5015875
 ;;^UTILITY(U,$J,358.3,23710,0)
 ;;=N87.1^^82^1032^46
 ;;^UTILITY(U,$J,358.3,23710,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23710,1,3,0)
 ;;=3^Cervical Dysplasia,Moderate
 ;;^UTILITY(U,$J,358.3,23710,1,4,0)
 ;;=4^N87.1
 ;;^UTILITY(U,$J,358.3,23710,2)
 ;;=^5015876
 ;;^UTILITY(U,$J,358.3,23711,0)
 ;;=N94.6^^82^1032^62
 ;;^UTILITY(U,$J,358.3,23711,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23711,1,3,0)
 ;;=3^Dysmenorrhea,Unspec
 ;;^UTILITY(U,$J,358.3,23711,1,4,0)
 ;;=4^N94.6
